ArticleBreast cancer research : BCR2019

Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51.

Jung Ok Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.